Cannon Financial Strategists, Inc. Zoetis Inc. Transaction History

Cannon Financial Strategists, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 01, 2024	SELL	$165.67 - $199.94 $140 Million - $168 Million	-842,106 Closed	0 $0
Q4 2023 Oct 01, 2024	BUY	$151.44 - $200.09 $128 Million - $168 Million	842,106 New	842,106 $70.2 Billion
Q3 2022 Oct 02, 2024	SELL	$148.29 - $182.55 $12.3 Million - $15.1 Million	-82,744 Closed	0 $0
Q2 2022 Oct 02, 2024	BUY	$155.97 - $200.09 $12.9 Million - $16.6 Million	82,744 New	82,744 $15.6 Billion

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Cannon Financial Strategists, Inc., based on Form 13F filings with the SEC.

Stay updated on Cannon Financial Strategists, Inc. with notifications on news.